Home » Topics » BioWorld Science

BioWorld Science
RSS

Anerem approved in Japan for general anesthesia

Jan. 24, 2020

Japanese approval for Corectim ointment for atopic dermatitis

Jan. 24, 2020

FDA grants accelerated approval of Tazverik for epithelioid sarcoma

Jan. 24, 2020

Norbinaltorphimine shown efficacious for preclinical autism and ADHD

Jan. 24, 2020

Study casts light on tumor initiating cells in breast cancer

Jan. 24, 2020

Metrion Biosciences describes new KCNA3 channel blockers

Jan. 24, 2020

Daiichi Sankyo identifies new EGFR and/or HER2 mutant inhibitors

Jan. 24, 2020

Janssen Pharmaceutica NV patents prostanoid EP3 receptor antagonists

Jan. 24, 2020

Shanghai Institute of Materia Medica patents GPR84 antagonists

Jan. 24, 2020

IFM Due discloses hSTING receptor antagonists

Jan. 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...